NCT00412815

Brief Summary

The purpose of this study was to determine the effects of exercise training on insulin resistance in subjects with coronary artery disease independent of changes in weight, diet, or the effect of an acute bout of exercise. We hypothesized that subjects with CAD and high normal or impaired glucose tolerance performing 12 weeks of aerobic exercise training while on a non weight-reducing diet, would have a greater decrease in insulin resistance than controls measured at 72 hours following their last bout of exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at below P25 for phase_3 coronary-artery-disease

Timeline
Completed

Started Nov 1998

Shorter than P25 for phase_3 coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 25, 1998

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2000

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2000

Completed
6.5 years until next milestone

First Submitted

Initial submission to the registry

December 14, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 18, 2006

Completed
Last Updated

August 28, 2017

Status Verified

August 1, 2017

Enrollment Period

1.5 years

First QC Date

December 14, 2006

Last Update Submit

August 25, 2017

Conditions

Keywords

insulin sensitivitycoronary artery diseaseexercise training

Outcome Measures

Primary Outcomes (1)

  • Insulin sensitivity

Secondary Outcomes (1)

  • Exercise capacity

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men and women over 18 years of age
  • fasting plasma glucose concentration 5.4-7.7 mmol/L
  • confirmed CAD (diagnosed on the basis of a previous myocardial perfusion study or cardiac catheterization, or a history of a myocardial infarction or coronary artery angioplasty or coronary artery bypass surgery).

You may not qualify if:

  • known type 1 or 2 diabetes
  • clinical heart failure
  • uncorrected significant valvular or congenital heart disease
  • significant obstructive pulmonary disease (forced expiratory volume in 1 sec / forced vital capacity \< 0.5)
  • uncontrolled hypertension (blood pressure \> 220 / 120 mm Hg)
  • participation in a regular exercise program within the preceding three months
  • inability to perform exercise training, atrial fibrillation
  • a permanent pacemaker
  • regularly used corticosteroid
  • recent (\< 3 months) myocardial infarction, unstable angina, coronary artery bypass graft surgery, or coronary artery angioplasty
  • run-in phase fasting blood glucose was \< 5.4 mmol/L or \> 11.1 mmol/L at 2 hours following the 75 gram oral glucose load.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamilton Health Sciences Centre

Hamilton, Ontario, L8L2X2, Canada

Location

MeSH Terms

Conditions

Coronary Artery DiseaseGlucose IntoleranceInsulin Resistance

Interventions

Exercise

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesHyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHyperinsulinism

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Robert S McKelvie, MD

    McMaster Univesrity

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2006

First Posted

December 18, 2006

Study Start

November 25, 1998

Primary Completion

June 9, 2000

Study Completion

June 9, 2000

Last Updated

August 28, 2017

Record last verified: 2017-08

Locations